System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Stefania Cerri is an expert in Pulmonology at Policlinico di Modena (Italy). As of October 2026, ScienceLeadR ranks Stefania Cerri in the top 1% of experts worldwide for Lung Diseases, Interstitial. Stefania Cerri has authored 161 publications, the most recent in 2026, and is an investigator in 19 clinical trials, 8 of them ongoing. SLR score: 871 (community average: 125). How the SLR is computed.

LeadR Profile

Stefania Cerri Policlinico di Modena Italy
871 ScienceLeadR Reputation 871

Unlock

Register Login
Network Map

Pulmonology

Subspecialties: Internal Medicine - Cardiology - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2009 - 2026
Source: PubMed

AOU Policlinico di Modena

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 161

Citations

Citations: 4 700 1st author: 11 Last author: 13 Unique author: 2

Main journals

Ann Rheum Dis 6
American Thoracic Society International Conference 5
BMC Pulm Med 5
J Clin Med 5
Respir Med 5

Best Journals

N Engl J Med 3
Lancet Respir Med 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Indirect Echocardiographic Signs of Increased Right-sided Afterload in Progressive Pulmonary Fibrosis: Insights from a Multicentre Italian Study.
PMID 42893460 — lung, fibrosis, respiration, signs and symptoms, pulmonary fibrosis, prevalence, sex, lung diseases		Lung20260
Association Between DLCO and Echocardiographic Right Ventricular-Pulmonary Arterial Coupling in Idiopathic Pulmonary Fibrosis.
PMID 42739835 — idiopathic pulmonary fibrosis, hypertension, fibrosis, pulmonary artery, arteries, pulmonary diffusing capacity, pulmonary fibrosis, echocardiography, ventricular function		J Clin Med20261
Non-invasive ventilation during severe asthma exacerbation: Physiological rationale, current evidence, and practical approach.
PMID 42735444 — noninvasive ventilation, muscles, therapeutics, asthma, lung diseases, ventilation, respiratory muscles		Respir Med Res20260
High treatment success in patients with microbiological and functional rifampicin resistance: results from a multicentre Italian cohort (RIFARES-ITA).
PMID 42537881 — treatment outcome, microbiology, parasitic diseases, therapeutics, communicable diseases, rifampin, infections		Clin Microbiol Infect20260
Why Men Fare Worse: Understanding Gender Disparities in Systemic Sclerosis-Associated Pulmonary Hypertension.
PMID 42495086 — sclerosis, hypertension, hypertension, pulmonary, prevalence, scleroderma, systemic		Clin Med Insights Cardiol20261

Clinical Studies 19

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4

By phase:

Phase 3 9
Phase 2 6
N/A 3
Phase 2/Phase 3 1

By status:

Completed 6
Recruiting 4
Not yet recruiting 3
Unknown 3
Terminated 2
Active not recruiting 1

By type:

Interventional 16
Observational 3

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 0
multicentric5to9 1
multicentricup10 17

Main Topics

Ongoing Clinical Trials

8 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Study of Intravenous ABBV 142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
2024-518013-25-00 — idiopathic pulmonary fibrosis, fibrosis, drug-related side effects and adverse reactions, pulmonary fibrosis, therapeutics		Phase 2Not yet recruiting2026
Clairleaf TM A study to test long term treatment with BI 1291583 in people with bronchiectasis who took part in a previous study with this medicine
2023-503290-38-00 — safety, therapeutics, bronchiectasis		Phase 2Active not recruiting2023
A Phase 3 Randomized Double blind Placebo controlled Multicenter Parallel Group Study to Evaluate the Efficacy and Safety of Trepostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
2025-521558-40-00 — hypertension, lung, hypertension, pulmonary, safety, powders, inhalation, therapeutics, lung diseases, lung diseases, interstitial		Phase 3Recruiting2026
Safety of Bronchoscopy in Patients With Interstitial Lung Disease
NCT07627594 — lung, safety, fibrosis, bronchoalveolar lavage, bronchoscopy, biopsy, endosonography, pulmonary fibrosis, lung diseases, lung diseases, interstitial		N/ANot yet recruiting2026
A follow up study to test long term treatment with BI 1015550 in people with pulmonary fibrosis who took part in a previous study with BI 1015550
2023-507353-15-00 — idiopathic pulmonary fibrosis, safety, follow-up studies, fibrosis, pulmonary fibrosis, therapeutics		Phase 3Recruiting2024

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS